4453 Total Publications
Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer’s Disease
McEvoy, L. K., Edland, S. D., Holland, D., Hagler, D. J., Roddey, J. C., Fennema-Notestine, C., … Dale, A. M.
PMID: 20683184
;
PMCID:2929320
; 2010; Journal Alzheimer's Disease and Associated Disorders; vol. 24; no. 3; pp. 269-77;
doi:10.1097/WAD.0b013e3181d1b814
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
Carmichael, O., Schwarz, C., Drucker, D., Fletcher, E., Harvey, D., Beckett, L., … DeCarli, C.
2010; Journal JAMA Neurology; vol. 67; no. 11; pp. 1370-1378;
doi:10.1001/archneurol.2010.284
Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection
Leung, K. K., Clarkson, M. J., Bartlett, J. W., Clegg, S., Jack Jr., C. R., Weiner, M. W., … Ourselin, S.
PMID: 20034579
;
PMCID:2828361
; 2010; Journal Neuroimage; vol. 50; no. 2; pp. 516-523;
doi:10.1016/j.neuroimage.2009.12.059
Automated cross-sectional and longitudinal hippocampal volume
measurement in mild cognitive impairment and Alzheimer's disease
Leung, K. K., Barnes, J., Ridgway, G. R., Bartlett, J. W., Clarkson, M. J., Macdonald, K., … Ourselin, S.
PMID: 20230901
;
PMCID:2873209
; 2010; Journal Neuroimage; vol. 51; no. 4; pp. 1345-1359;
doi:10.1016/j.neuroimage.2010.03.018
Validating predicted biological effects of Alzheimer's disease associated SNPs using cerebrospinal fluid biomarker levels
Kauwe, J. S. K., Cruchaga, C., Bertelsen, S., Mayo, K., Latu, W., Nowotny, P., … Goate, A. M.
PMID: 20634593
;
PMCID:3032214
; 2010; Journal Journal of Alzheimer's Disease; vol. 21; no. 3; pp. 833-42;
doi:10.3233/JAD-2010-091711
Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations
Evans, M. C., Barnes, J., Nielsen, C., Kim, L. G., Clegg, S. L., Blair, M., … Fox, N. C.
PMID: 19760240
; 2010; Journal European Radiology; vol. 20; no. 3; pp. 674-82;
doi:10.1007/s00330-009-1581-5
Disease progression meta-analysis model in Alzheimer’s disease
Ito, K., Ahadieh, S., Corrigan, B., French, J., Fullerton, T., & Tensfeldt, T.
PMID: 19592311
; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 1; pp. 39-53;
doi:10.1016/j.jalz.2009.05.665
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
Walhovd, K. B., Fjell, a M., Brewer, J., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., … Dale, a M.
PMID: 20075088
;
PMCID:2821467
; 2010; Journal AJNR; vol. 31; no. 2; pp. 347-54;
doi:10.3174/ajnr.A1809
CEREBRAL ATROPHY, APOLIPOPROTEIN E ε4, AND RATE OF DECLINE IN EVERYDAY FUNCTION AMONG PATIENTS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT
Okonkwo, O. C., Alosco, M. L., Jerskey, B. A., Sweet, L. H., Ott, B. R., & Tremont, G.
PMID: 20813341
;
PMCID:2950092
; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 404-11;
doi:10.1016/j.jalz.2010.02.003